Journal of Chemical Information and Modeling,
Год журнала:
2023,
Номер
64(1), С. 76 - 95
Опубликована: Дек. 18, 2023
Artificial
intelligence
has
made
significant
advances
in
the
field
of
protein
structure
prediction
recent
years.
In
particular,
DeepMind's
end-to-end
model,
AlphaFold2,
demonstrated
capability
to
predict
three-dimensional
structures
numerous
unknown
proteins
with
accuracy
levels
comparable
those
experimental
methods.
This
breakthrough
opened
up
new
possibilities
for
understanding
and
function
as
well
accelerating
drug
discovery
other
applications
biology
medicine.
Despite
remarkable
achievements
artificial
field,
there
are
still
some
challenges
limitations.
this
Review,
we
discuss
progress
prediction.
These
include
predicting
multidomain
structures,
complex
multiple
conformational
states
proteins,
folding
pathways.
Furthermore,
highlight
directions
which
further
improvements
can
be
conducted.
Drug Design Development and Therapy,
Год журнала:
2023,
Номер
Volume 17, С. 2691 - 2725
Опубликована: Сен. 1, 2023
Abstract:
Artificial
intelligence
(AI)
and
machine
learning
(ML)
represent
significant
advancements
in
computing,
building
on
technologies
that
humanity
has
developed
over
millions
of
years—from
the
abacus
to
quantum
computers.
These
tools
have
reached
a
pivotal
moment
their
development.
In
2021
alone,
U.S.
Food
Drug
Administration
(FDA)
received
100
product
registration
submissions
heavily
relied
AI/ML
for
applications
such
as
monitoring
improving
human
performance
compiling
dossiers.
To
ensure
safe
effective
use
drug
discovery
manufacturing,
FDA
numerous
other
federal
agencies
issued
continuously
updated,
stringent
guidelines.
Intriguingly,
these
guidelines
are
often
generated
or
updated
with
aid
themselves.
The
overarching
goal
is
expedite
discovery,
enhance
safety
profiles
existing
drugs,
introduce
novel
treatment
modalities,
improve
manufacturing
compliance
robustness.
Recent
publications
offer
an
encouraging
outlook
potential
tools,
emphasizing
need
careful
deployment.
This
expanded
market
opportunities
retraining
personnel
handling
enabled
innovative
emerging
therapies
gene
editing,
CRISPR-Cas9,
CAR-T
cells,
mRNA-based
treatments,
personalized
medicine.
summary,
maturation
testament
ingenuity.
Far
from
being
autonomous
entities,
created
by
humans
designed
solve
complex
problems
now
future.
paper
aims
present
status
technologies,
along
examples
future
applications.
Keywords:
FDA,
artificial
intelligence,
learning,
development,
advanced
Google
DeepMind
Technologies
Limited
(London,
United
Kingdom)
recently
released
its
new
version
of
the
biomolecular
structure
predictor
artificial
intelligence
(AI)
model
named
AlphaFold
3.
Superior
in
accuracy
and
more
powerful
than
predecessor
2,
this
innovation
has
astonished
world
with
capacity
speed.
It
takes
humans
years
to
determine
various
proteins
how
shape
works
receptors
but
3
predicts
same
seconds.
The
version's
utility
is
unimaginable
field
drug
discoveries,
vaccines,
enzymatic
processes,
determining
rate
effect
different
biological
processes.
uses
similar
machine
learning
deep
models
such
as
Gemini
(Google
Limited).
already
established
itself
a
turning
point
computational
biochemistry
development
along
receptor
modulation
development.
With
help
this,
researchers
will
gain
unparalleled
insights
into
structural
dynamics
their
interactions,
opening
up
avenues
for
scientists
doctors
exploit
benefit
patient.
integration
AI
like
3,
bolstered
by
rigorous
validation
against
high-standard
research
publications,
set
catalyze
further
innovations
offer
glimpse
future
biomedicine.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(15), С. 8426 - 8426
Опубликована: Авг. 1, 2024
Protein
structure
prediction
is
important
for
understanding
their
function
and
behavior.
This
review
study
presents
a
comprehensive
of
the
computational
models
used
in
predicting
protein
structure.
It
covers
progression
from
established
modeling
to
state-of-the-art
artificial
intelligence
(AI)
frameworks.
The
paper
will
start
with
brief
introduction
structures,
modeling,
AI.
section
on
discuss
homology
ab
initio
threading.
next
deep
learning-based
models.
introduces
some
AI
models,
such
as
AlphaFold
(AlphaFold,
AlphaFold2,
AlphaFold3),
RoseTTAFold,
ProteinBERT,
etc.
also
discusses
how
techniques
have
been
integrated
into
frameworks
like
Swiss-Model,
Rosetta,
I-TASSER.
model
performance
compared
using
rankings
CASP14
(Critical
Assessment
Structure
Prediction)
CASP15.
CASP16
ongoing,
its
results
are
not
included
this
review.
Continuous
Automated
Model
EvaluatiOn
(CAMEO)
complements
biennial
CASP
experiment.
Template
score
(TM-score),
global
distance
test
total
(GDT_TS),
Local
Distance
Difference
Test
(lDDT)
discussed
too.
then
acknowledges
ongoing
difficulties
emphasizes
necessity
additional
searches
dynamic
behavior,
conformational
changes,
protein-protein
interactions.
In
application
section,
applications
various
fields
drug
design,
industry,
education,
novel
development.
summary,
provides
overview
latest
advancements
predictions.
significant
achieved
by
identifies
potential
areas
further
investigation.
Pharmacology & Therapeutics,
Год журнала:
2025,
Номер
unknown, С. 108797 - 108797
Опубликована: Янв. 1, 2025
The
traditional
model
of
protein
structure
determined
by
the
amino
acid
sequence
is
today
seriously
challenged
fact
that
approximately
half
human
proteome
made
up
proteins
do
not
have
a
stable
3D
structure,
either
partially
or
in
totality.
These
proteins,
called
intrinsically
disordered
(IDPs),
are
involved
numerous
physiological
functions
and
associated
with
severe
pathologies,
e.g.
Alzheimer,
Parkinson,
Creutzfeldt-Jakob,
amyotrophic
lateral
sclerosis
(ALS),
type
2
diabetes.
Targeting
these
challenging
for
two
reasons:
i)
we
need
to
preserve
their
functions,
ii)
drug
design
molecular
docking
possible
due
lack
reliable
starting
conditions.
Faced
this
challenge,
solutions
proposed
artificial
intelligence
(AI)
such
as
AlphaFold
clearly
unsuitable.
Instead,
suggest
an
innovative
approach
consisting
mimicking,
short
synthetic
peptides,
conformational
flexibility
IDPs.
which
call
adaptive
derived
from
domains
IDPs
become
structured
after
interacting
ligand.
Adaptive
peptides
designed
aim
selectively
antagonizing
harmful
effects
IDPs,
without
targeting
them
directly
but
through
selected
ligands,
affecting
properties.
This"target
target,
arrow"
strategy
promised
open
new
route
discovery
currently
undruggable
proteins.
Current Issues in Molecular Biology,
Год журнала:
2023,
Номер
45(4), С. 3705 - 3732
Опубликована: Апрель 21, 2023
Elucidation
of
the
tertiary
structure
proteins
is
an
important
task
for
biological
and
medical
studies.
AlphaFold,
a
modern
deep-learning
algorithm,
enables
prediction
protein
to
high
level
accuracy.
It
has
been
applied
in
numerous
studies
various
areas
biology
medicine.
Viruses
are
entities
infecting
eukaryotic
procaryotic
organisms.
They
can
pose
danger
humans
economically
significant
animals
plants,
but
they
also
be
useful
control,
suppressing
populations
pests
pathogens.
AlphaFold
used
molecular
mechanisms
viral
infection
facilitate
several
activities,
including
drug
design.
Computational
analysis
bacteriophage
receptor-binding
contribute
more
efficient
phage
therapy.
In
addition,
predictions
discovery
enzymes
origin
that
able
degrade
cell
wall
bacterial
The
use
assist
fundamental
research,
evolutionary
ongoing
development
improvement
ensure
its
contribution
study
will
future.
Natural Products and Bioprospecting,
Год журнала:
2024,
Номер
14(1)
Опубликована: Янв. 11, 2024
Abstract
Metagenomics
has
opened
new
avenues
for
exploring
the
genetic
potential
of
uncultured
microorganisms,
which
may
serve
as
promising
sources
enzymes
and
natural
products
industrial
applications.
Identifying
with
improved
catalytic
properties
from
vast
amount
available
metagenomic
data
poses
a
significant
challenge
that
demands
development
novel
computational
functional
screening
tools.
The
all
are
primarily
dictated
by
their
structures,
predominantly
determined
amino
acid
sequences.
However,
this
aspect
not
been
fully
considered
in
enzyme
bioprospecting
processes.
With
accumulating
number
sequences
increasing
demand
discovering
biocatalysts,
structural
modeling
can
be
employed
to
identify
properties.
Recent
efforts
discover
polysaccharide-degrading
rumen
metagenome
using
homology-based
searches
machine
learning-based
models
have
shown
promise.
Here,
we
will
explore
various
approaches
screen
shortlist
metagenome-derived
biocatalyst
candidates,
conjunction
wet
lab
analytical
methods
traditionally
used
characterization.
International Journal of Molecular Sciences,
Год журнала:
2024,
Номер
25(3), С. 1798 - 1798
Опубликована: Фев. 1, 2024
Over
the
last
few
decades,
we
have
witnessed
growing
interest
from
both
academic
and
industrial
laboratories
in
peptides
as
possible
therapeutics.
Bioactive
a
high
potential
to
treat
various
diseases
with
specificity
biological
safety.
Compared
small
molecules,
represent
better
candidates
inhibitors
(or
general
modulators)
of
key
protein–protein
interactions.
In
fact,
undruggable
proteins
containing
large
smooth
surfaces
can
be
more
easily
targeted
conformational
plasticity
peptides.
The
discovery
bioactive
peptides,
working
against
disease-relevant
protein
targets,
generally
requires
high-throughput
screening
libraries,
silico
approaches
are
highly
exploited
for
their
low-cost
incidence
efficiency.
present
review
reports
on
challenges
linked
employment
therapeutics
describes
computational
approaches,
mainly
structure-based
virtual
(SBVS),
support
identification
novel
therapeutic
implementations.
Cutting-edge
SBVS
strategies
reviewed
along
examples
applications
focused
diverse
classes
(i.e.,
anticancer,
antimicrobial/antiviral
blocking
amyloid
fiber
formation).